Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junjiro Tsuchiyama

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Internal Medicine (Tokyo, Japan)|November 17, 2009
Successful treatment of KIT D816V-positive, imatinib-resistant systemic mastocytosis with interferon-alphaChikamasa Yoshida, Makoto Takeuchi, Junjiro Tsuchiyama, et al.
Leukemia & Lymphoma|February 13, 2004
Physiological oxidants induce apoptosis and cell cycle arrest in a multidrug-resistant natural killer cell line, NK-YSTin Aung Than, Tetsuya Ogino, Mutsumi Hosako, et al.
Leukemia Research|January 5, 2002
Acute T-lymphoblastic leukemia relapsed with the character of myeloid/natural killer cell precursor phenotype: a case reportShigeo Hashimoto, Ken Toba, Sadao Aoki, et al.
Leukemia Research|May 15, 2002
Cutaneous lymphoblastic lymphoma of putative plasmacytoid dendritic cell-precursor origin: two casesAkihito Momoi, Ken Toba, Kazuhiro Kawai, et al.
Leukemia Research|January 17, 2002
CD56+, NKp46+ cell line (MZ93) expressing T-cell and myeloid antigensShigeo Hashimoto, Ken Toba, Junjiro Tsuchiyama, et al.
Cytometry. Part B, Clinical Cytometry|March 3, 2004
Sensitive measurement of fragmented red cell population using flow cytometry, and its application for estimating thrombotic microangiopathy after stem cell transplantationKen Toba, Junjiro Tsuchiyama, Shigeo Hashimoto, et al.
Molecular Cancer Therapeutics|December 17, 2008
Cell death by bortezomib-induced mitotic catastrophe in natural killer lymphoma cellsLijun Shen, Wing-Yan Au, Kai-Yau Wong, et al.
British Journal of Haematology|July 26, 2002
Induction and characterization of cutaneous lymphocyte antigen on natural killer cellsJunjiro Tsuchiyama, Tadashi Yoshino, Ken Toba, et al.
International Journal of Cancer|December 31, 2008
Frequent concomitant epigenetic silencing of the stress-responsive tumor suppressor gene CADM1, and its interacting partner DAL-1 in nasal NK/T-cell lymphomaLi Fu, Zifen Gao, Xiaohua Zhang, et al.
Leukemia Research|January 16, 2003
Fc epsilon RI and CD22 mRNA are expressed in early B-lineage and myeloid leukemia cell linesKen Toba, Haruo Hanawa, Minori Sakaue, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Internal Medicine (Tokyo, Japan)|November 17, 2009
Successful treatment of KIT D816V-positive, imatinib-resistant systemic mastocytosis with interferon-alphaChikamasa Yoshida, Makoto Takeuchi, Junjiro Tsuchiyama, et al.
Leukemia & Lymphoma|February 13, 2004
Physiological oxidants induce apoptosis and cell cycle arrest in a multidrug-resistant natural killer cell line, NK-YSTin Aung Than, Tetsuya Ogino, Mutsumi Hosako, et al.
Leukemia Research|January 5, 2002
Acute T-lymphoblastic leukemia relapsed with the character of myeloid/natural killer cell precursor phenotype: a case reportShigeo Hashimoto, Ken Toba, Sadao Aoki, et al.
Leukemia Research|May 15, 2002
Cutaneous lymphoblastic lymphoma of putative plasmacytoid dendritic cell-precursor origin: two casesAkihito Momoi, Ken Toba, Kazuhiro Kawai, et al.
Leukemia Research|January 17, 2002
CD56+, NKp46+ cell line (MZ93) expressing T-cell and myeloid antigensShigeo Hashimoto, Ken Toba, Junjiro Tsuchiyama, et al.
Cytometry. Part B, Clinical Cytometry|March 3, 2004
Sensitive measurement of fragmented red cell population using flow cytometry, and its application for estimating thrombotic microangiopathy after stem cell transplantationKen Toba, Junjiro Tsuchiyama, Shigeo Hashimoto, et al.
Molecular Cancer Therapeutics|December 17, 2008
Cell death by bortezomib-induced mitotic catastrophe in natural killer lymphoma cellsLijun Shen, Wing-Yan Au, Kai-Yau Wong, et al.
British Journal of Haematology|July 26, 2002
Induction and characterization of cutaneous lymphocyte antigen on natural killer cellsJunjiro Tsuchiyama, Tadashi Yoshino, Ken Toba, et al.
International Journal of Cancer|December 31, 2008
Frequent concomitant epigenetic silencing of the stress-responsive tumor suppressor gene CADM1, and its interacting partner DAL-1 in nasal NK/T-cell lymphomaLi Fu, Zifen Gao, Xiaohua Zhang, et al.
Leukemia Research|January 16, 2003
Fc epsilon RI and CD22 mRNA are expressed in early B-lineage and myeloid leukemia cell linesKen Toba, Haruo Hanawa, Minori Sakaue, et al.
Pageof 2